Biofrontera AG
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany. Show More...
-
Website https://www.biofrontera.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 2.54 EUR
-
Last Updated 22-07-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR -0.71 -0.36 -0.22 -0.3 -0.41 -0.46 -0.36 -0.42 -0.2 -0.16 -0.24 Dividends EUR Payout Ratio % * Shares Mil 11.0 13.0 27.0 27.0 26.0 24.0 30.0 38.0 44.0 45.0 44.0 Book Value Per Share * EUR -0.87 -0.91 -0.05 -0.010 0.1 -0.2 -0.07 0.12 0.29 0.32 0.1 Free Cash Flow Per Share * EUR -0.22 -0.57 -0.14 -0.39 -0.27 -0.36 -0.27 -0.43 -0.29 -0.58 Return on Assets % -258.13 -112.39 -55.9 -86.4 -90.67 -95.31 -63.39 -73.65 -30.1 -15.68 -22.31 Financial Leverage (Average) 1.51 5.87 2.39 5.86 11.83 Return on Equity % -191.77 -167.53 -89.96 -58.11 -118.4 Return on Invested Capital % -69.5 -84.25 -33.32 -18.45 -29.09 Interest Coverage -7.31 -8.59 -7.76 -13.21 -9.8 -0.76 -1.72 Current Ratio 0.38 0.15 2.53 2.77 3.4 2.35 4.95 4.49 3.55 1.94 1.74 Quick Ratio 0.33 0.08 1.89 2.0 2.95 1.83 4.09 3.23 3.05 1.49 1.19 Debt/Equity 0.23 3.65 0.82 2.22 5.14